Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement
Ankit Parikh, Krishna Kathawala, Chun Chuan Tan, Sanjay Garg, Xin-Fu Zhou School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia Background: Edaravone (EDR) is known for its free radical scavenging, antiapoptotic, antinecrotic, and anticytokine effects in neu...
Saved in:
Main Authors: | Parikh A (Author), Kathawala K (Author), Tan CC (Author), Garg S (Author), Zhou XF (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model
by: Parikh A, et al.
Published: (2018) -
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
by: Ankit Parikh, et al.
Published: (2017) -
Atorvastatin solid dispersion for bioavailability enhancement
by: Shamsuddin, et al.
Published: (2016) -
Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of Curcumin
by: Jae Geun Song, et al.
Published: (2022) -
Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion
by: Mohammad A. Altamimi, et al.
Published: (2019)